Jong Joseph Kim - 08 Mar 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Executive Officer, Director
Signature: /s/ Jong Joseph Kim
Issuer symbol: INO
Transactions as of: 08 Mar 2022
Net transactions value: -$59,143
Form type: 4
Filing time: 09 Mar 2022, 15:07:49 UTC
Previous filing: 01 Mar 2022
Next filing: 14 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+63,700	+5%		1,341,080	08 Mar 2022	Direct	F1
transaction	INO	Common Stock	Tax liability	$59,143	-18,142	-1.4%	$3.26^*	1,322,938	08 Mar 2022	Direct	F2
holding	INO	Common Stock						816,527	08 Mar 2022	By Family Limited Partnership
holding	INO	Common Stock						33,563	08 Mar 2022	By Daughter: EK
holding	INO	Common Stock						33,775	08 Mar 2022	By Son: JK1
holding	INO	Common Stock						5,975	08 Mar 2022	By Spouse
holding	INO	Common Stock						33,533	08 Mar 2022	By Son: JK2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-63,700	-100%	$0.000000^*	0	08 Mar 2022	Common Stock	63,700		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 191,100 restricted stock units is as follows: 63,700 shares vested on March 8, 2020; 63,700 shares vested on March 8, 2021; 63,700 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.